Read More Pharma Industry News Sirius Therapeutics launches SRSD107 Phase 1 trial, targeting thromboembolic disorders Sirius Therapeutics, a pioneering biotechnology firm, has marked a significant milestone in the development of novel treatments for… byPallavi MadhirajuFebruary 4, 2024